ITGB2 (Integrin β2) Immunomodulatory Gene Variants in Premature Infants With Necrotizing Enterocolitis

Area of Science:

• Immunology
• Neonatal research
• Genetics

Background:

• Aberrant toll-like receptor (TLR) activation is a key factor in necrotizing enterocolitis (NEC) development.
• Integrin beta 2 (ITGB2) plays a role in regulating TLR signaling; its deficiency can lead to TLR hyperresponsiveness.

Purpose of the Study:

• To investigate if genetic variants in the ITGB2 gene influence susceptibility to NEC in preterm infants.
• To determine the association between ITGB2 genetic variants and NEC development and severity.

Main Methods:

• Sequencing of the exonic ITGB2 locus in 221 preterm infants (with and without NEC).
• Comparison of ITGB2 variant prevalence between NEC cases and controls, including subgroup analysis for extremely low birthweight (ELBW) infants.
• Utilizing Combined Annotation-Dependent Depletion (CADd) to predict deleterious variants.

Main Results:

• No significant association was found between ITGB2 variants and NEC in the overall preterm cohort or in ELBW infants.
• Prevalence of ITGB2 variants in the cohort was higher than in the general population.
• Deleterious ITGB2 variants showed a proportional increase with NEC severity in ELBW infants (medical and surgical NEC).

Conclusions:

• While ITGB2 variants were not directly associated with NEC in this preterm cohort, a trend suggests a potential role in NEC severity, particularly in ELBW infants.
• Further research is warranted to explore the specific mechanisms linking ITGB2 variants to NEC pathogenesis and severity in vulnerable infant populations.